Case report: Sotrovimab, remdesivir and nirmatrelvir/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19Federico Baldi, Matteo Bassetti, Michele Mirabella et al.|Frontiers in Medicine|2023Cited by 35
Trojan-horse silk fibroin nanocarriers loaded with a re-call antigen to redirect immunity against cancerElia Bari, Gilberto Filaci|Journal for ImmunoTherapy of Cancer|2023Cited by 10
A simple cell proliferation assay and the inflammatory protein content show significant differences in human plasmas from young and old subjectsAnita Muraglia, Maddalena Mastrogiacomo, Olga Utyro et al.|Frontiers in Bioengineering and Biotechnology|2024Cited by 2